Zavante Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Zavante Therapeutics is developing and marketing.
Zavante Therapeutics doesn't have any recent trademark applications, indicating Zavante Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ZOLYD Pharmaceuticals, namely, anti-infectives
03/13/2017
CONTEPO Pharmaceuticals, namely, anti-infectives
03/13/2017
ZAVANTE THERAPEUTICS, INC. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
06/08/2014
See all trademarks and details in the Full Report.
Market Share of Zavante Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Zavante Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Zavante Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Zavante Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.